Non-small cell lung carcinoma with co-expression of thyroid transcription factor-1 and p40: a case report and literature review

NSCLC with co-expression of Thyroid Transcription Factor-1 and p40 is a rare and diagnostically challenging subtype, most frequently observed in older male patients with a history of smoking and predominantly arising in peripheral lung regions. The morphological, immunophenotypic and molecular features of these tumors suggest that they may originate from stem-like basal cells with dual-lineage differentiation. Literature review identified high-frequency alterations in TP53, FGFR1, CDKN2A, EGFR, KRAS, MYC, NF1 and AKT1. Next-generation sequencing-based genomic profiling facilitate the diagnosis and treatment of such cases.

Authors

Institutions

Publication Details

Journal
World Journal of Surgical Oncology
Published
2025-11-24
DOI
https://doi.org/10.1186/s12957-025-04103-7
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Non-small cell lung carcinoma with co-expression of thyroid transcription factor-1 and p40: a case report and literature review

Yuanzhi Lu, C Wei, Yishan Wang, Weijia Lu et al.
World Journal of Surgical Oncology
Lung Cancer Treatments and Mutations
article

Non-small cell lung carcinoma with co-expression of thyroid transcription factor-1 and p40: a case report and literature review

Yuanzhi Lu, C Wei, Yishan Wang, Weijia Lu, Biyun Lin, Danhui Gan
article en

Abstract

NSCLC with co-expression of Thyroid Transcription Factor-1 and p40 is a rare and diagnostically challenging subtype, most frequently observed in older male patients with a history of smoking and predominantly arising in peripheral lung regions. The morphological, immunophenotypic and molecular features of these tumors suggest that they may originate from stem-like basal cells with dual-lineage differentiation. Literature review identified high-frequency alterations in TP53, FGFR1, CDKN2A, EGFR, KRAS, MYC, NF1 and AKT1. Next-generation sequencing-based genomic profiling facilitate the diagnosis and treatment of such cases.

World Journal of Surgical OncologyVol. 23(1)
Guangdong Medical College (CN), First Affiliated Hospital of Jinan University (CN)
Openalex Percentile: Top 48%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Non-small cell lung carcinoma with co-expression of thyroid transcription factor-1 and p40: a case report and literature review — Yuanzhi Lu, C Wei, et al. · World Journal of Surgical Oncology (2025) | TGRS Research Map | TGRS